Abstract
Background
Adolescents with ADHD are at increased risk of adverse outcomes and a negative life trajectory into adulthood. Evidence regarding treatment specifically tailored for the needs of this age group are still limited. High dropout rates, discontinuation of medication and treatment resistance are common issues in this population, and the patient perspective on new treatment options is therefore important. In this study, we aimed to investigate treatment satisfaction and feasibility of a group CBT program for adolescents with ADHD. We further aimed to identify any baseline characteristics predicting satisfaction.
Materials and methods
This study was part of a larger RCT of group CBT as add-on treatment for adolescents aged 14–18 years (Mean age 15.9 years, SD 1.3) with ADHD in Norway. Satisfaction and feasibility in the treatment group (n = 48) were measured by completion of an evaluation questionnaire, attendance of group sessions and a group-leaders checklist. Predictors of satisfaction were analysed using linear regression.
Results
Overall satisfaction was very high with a significant age effect, the eldest participants being most satisfied. Attendance rate was high with few dropouts and medical adherence during the treatment period was good. Group-leaders generally self-evaluated adherence to treatment manual positively but addressing resistance towards homework as challenging.
Conclusions
The participants were very satisfied with the group CBT treatment. Treatment options that are accepted and well-liked by the targeted population have the potential of reducing resistance towards treatment, improving future health and adherence to medication. The program is considered suitable for a clinical setting and may represent a feasible treatment supplement for adolescent ADHD.
Acknowledgements
The authors wish to thank adolescents and their families for participating in this study.
Disclosure statement
AMS has received travel support and congress fee from MEDICE in the last 3 years. PHT has received speaker’s fee from MEDICE and Shire in the last 3 years. SY has received honoraria for consultation and/or educational talks in the last 5 years from Janssen, HB Pharma and/or Shire. She is the author of “ADHD Child Evaluation (ACE) and ACE+ (for adults), and lead author of “R&R2 for ADHD Youths and Adults”. TSN has received a speaker’s fee from MEDICE in the last 3 years.
Additional information
Funding
Notes on contributors
Ann Christin Andersen
Ann Christin Andersen, MD, is a Consultant Child and Adolescent Psychiatrist and a PhD-candidate. She is also a trained CBT therapist and certified CBT supervisor.
Anne Mari Sund
Anne Mari Sund, MD, PhD, is a Child and Adolescent Psychiatrist and Professor. Her research interests are spanning from large epidemiological studies to preventive and clinical RCT studies. She is also a CBT therapist and certified CBT Supervisor.
Per Hove Thomsen
Per Hove Thomsen, MD, PhD, is a Consultant Child and Adolescent Psychiatrist and appointed Professor and head of the research unit. His main research areas are OCD, ADHD, eating disorders and autism.
Stian Lydersen
Stian Lydersen, PhD, is professor of medical statistics. He is one of the authors of the books “Medical Statistics in Clinical and Epidemiological Research” (2012) and “Statistical Analysis of Contingency Tables” (2017).
Susan Young
Susan Young, BSc (Hons), DClinPsy, PhD, CSi, AFBPS is a clinical and forensic psychologist, and a practitioner neuropsychologist. She is the director of Psychology Services Limited and is an Honorary Professor in the Department of Psychology at Reykjavik University.
Torunn Stene Nøvik
Torunn Stene Nøvik, MD, PhD, is a Consultant Child and Adolescent Psychiatrist and Associate Professor. Her current clinical and research interests include the assessment and treatment of children and adolescents with mood disorders and neurodevelopmental disorders.